Phase II Study of Continuous Daily Sunitinib Dosing in Patients with Previously Treated Advanced Non–Small-Cell Lung Cancer (NSCLC)

Autor: Scagliotti, G.V., Gillenwater, H.H., Brahmer, J.R., Govindan, R., Rosell, R., Belani, C.P., Atkins, J.N., Tye, L., Chao, R., Socinski, M.A.
Zdroj: In Clinical Lung Cancer July 2007 8(7):451-451
Databáze: ScienceDirect